Violation Tracker Individual Record

Company: 
Geneva Pharmaceuticals
Current Parent Company: 
Novartis
Penalty: 
$15,350,000
Year: 
2005
Date: 
June 14, 2005
Offense Group: 
competition-related offenses
Primary Offense: 
price-fixing or anti-competitive practices
Violation Description: 

Abbott Laboratories and Geneva Pharmaceuticals agreed to pay a total of $30.7 million to settle multistate litigation alleging that they conspired to engage in anticompetitive conduct that delayed the availability of a more affordable generic version of the medication Hytrin. The annoluncement did not specify how much each company would pay. Here we assume the amount was divided equally between them.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Switzerland
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.